openPR Logo
Press release

Pulmonary Drugs 2024 Market Research Report

04-07-2017 08:42 PM CET | Health & Medicine

Press release from: Transparency Market Research

Global Pulmonary Drugs Market: Snapshot

The global pulmonary drugs market has been the key area of focus and the most crucial market for the healthcare industry in the last couple of years. However, the market is expected to witness a significant decline over the forecast period with a -6.3% CAGR from 2016 to 2024. The market is anticipated to fall to US$28,082.1 mn from a valuation of US$48,039.7 mn in 2015. Keeping aside the tremendous fall of the global pulmonary drugs market, it has been expected that the market will find growth prospects from the growing number of respiratory diseases and the fact that they are becoming the leading cause of deaths across the globe at present, especially among the aged population.

Download The Full Brouchre of Report:

According to the Forum of International Respiratory Societies (FIRS), chronic obstructive pulmonary disease affects over 200 million people across the globe and is also one of the leading causes of death globally. On the other, over 235 million people across the globe suffer from asthma. Owing to these alarming statistics, the consumption of pulmonary drugs is likely to gain momentum, thus providing growth opportunities to the market in spite of the negative CAGR. Pulmonary drugs are also being employed for the treatment of conditions such as cystic fibrosis, respiration-related disorders, pulmonary arterial hypertension (PAH), and allergic rhinitis. The launch of many effective and innovative drugs in the global market for pulmonary drugs is also anticipated to have a positive impact on the growth of the market in the coming years.

Medical Professionals to Prefer Combination Drugs among All Others

Based on drug classes, the global market for pulmonary drugs is classified into combination drugs, anticholinergics, short acting beta2-agonists, vasodilators, antihistamines, long-acting beta2-agonists, and inhaled corticosteroids, and others such as antileukotrienes, antibiotics, enzymes, and monoclonal antibodies. Among these, the segment of combination drugs held the leading share of 27.4% in 2015 closely followed by inhaled corticosteroids with a share of 16.7% in the same year in the global pulmonary drugs market. The sales of combination drugs is likely to remain high throughout the forecast period as they are considered to be comparatively safer than the other drugs. Moreover, the advent of triple combination drugs is further projected to propel the growth of the global pulmonary drugs market over the course of the forecast period.

Advent of Middle-income Classes to Catapult Demand in Asia Pacific

Based on geography, the global market for pulmonary drugs has been classified into Asia Pacific, North America, Europe, the Middle East and Africa, and Latin America. In 2015, North America led the global pulmonary drugs market with a share of 41% with Europe closely following with a share of 32.4% in the same year. The growing use of pulmonary drugs in these regions can be attributed to the advanced healthcare infrastructure coupled with high awareness regarding treatment of pulmonary diseases. However, the rise of middle-income classes and their growing expenditure on healthcare is expected to lift Asia Pacific as a prominent region in the global market.

Browse Global Strategic Business Report:

Some of the leading players in the market are Actelion Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Merck & Co., Inc, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, AstraZeneca plc, and Sunovion Pharmaceuticals Inc.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Drugs 2024 Market Research Report here

News-ID: 496036 • Views: 534

More Releases from Transparency Market Research

Analysis of COVID-19 Crisis-driven Growth Opportunities in Diabetic Ulcers Treat …
The global diabetic ulcers treatment market was valued at approximately US$ 7.3 Bn in 2017. It is projected to expand at a compound annual growth rate (CAGR) of more than 7.0% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled ‘Diabetic Ulcers Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ Expansion of the health care industry, government initiatives,
Acute Lymphoblastic Leukemia Market - Industry Trends, Size, Growth Insight, Sha …
Transparency Market Research (TMR) has published a new report titled, “Acute Lymphoblastic Leukemia Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global acute lymphoblastic leukemia market was valued at US$ 1,627.5 Mn in 2017. It is projected to expand at a CAGR of 8.1% from 2018 to 2026. Expansion of the pharmaceutical industry, government initiatives, increase in health care expenditure, surge
Prosthetics Market Size, Share, Trends, Growth, Forecast Analysis Report by Prod …
Global Prosthetics Market: Introduction According to the report, the global prosthetics market was valued at ~US$ 8.9 Bn in 2018 and is projected to expand at a high CAGR during the forecast period. Prosthetics refers to the science of developing prosthesis, which are artificial substitutes or replacement for a lost body part, including arm, limb, eye, facial bone and tooth. These are designed for both functional and cosmetic reasons. The global
Antihypertensive Drugs Market Trends by Manufacturers, States, Type and Applicat …
Antihypertensive Drugs Market: Introduction According to the report, the global antihypertensive drugs market was valued at ~US$ 27.8 Bn in 2018 and is projected to expand at a CAGR of ~2% from 2019 to 2027 Stroke, also known as cerebrovascular accident, is a medical condition that occurs when the blood supply to the brain is interrupted or blocked. It leads to sudden death of brain cells due to lack of oxygen, which

All 5 Releases

More Releases for TMR

TMR Research
Global 3D Animation Market: Snapshot The evolution and introduction of three-dimensional (3D) animation has given the world of animation a new perspective. The process of creating 3D moving images in a digital space through objects or models has given these illusions depth. One of the most fundamental differences between 2D animation and 3D animation is the technique used for creating the images and the way they look. The global 3D animation
Various strategies are leveraged by success-hungry players in the global hyperbaric oxygen therapy devices market. One of them is the thrust on research and development to come up with new or better products. Their focus is on building cost-effective medical devices that would see greater uptake. Strategic partnerships are also being undertaken by them to diversify product portfolios and gain greater share. Further, companies are shifting their gaze to developing
Monolithic Ceramics Market Analysis : TMR
Transparency Market Research has published a new market report titled “Monolithic Ceramics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023.” According to the report, the global monolithic ceramics market was valued at US$ 19.43 Bn in 2014 and is anticipated to reach US$ 36.64 Bn by 2023, expanding at a CAGR of 7.3% between 2015 and 2023. Request to view Sample Report: Monolithic ceramics are
Wax Market Analysis : TMR
A recent research report published by Transparency Market Research projects the global wax market to expand at a CAGR of 2.6% during the period between 2014 and 2020. The report, titled “Wax Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” estimates the global wax market to be worth US$8.98 bn by 2020. The overall market stood at a valuation of US$8.21 bn in 2013
Subsea Boosting Systems Market Analysis : TMR
Due to a limited number of manufacturers of subsea boosting systems, the degree of competition in the global subsea boosting systems market is expected to substantially increase, reports Transparency Market Research (TMR) in a new study. The leading manufacturers of subsea boosting systems are focusing on pricing strategies to attract consumers and maintain their leading position in the industry. The top three companies, FMC Technologies, OneSubsea, and GE Oil &
Sulfone Polymers Market Analysis : TMR
Global Sulfone Polymers Market: Snapshot Several grades/varieties of sulfone polymers have gained vast applicability across a number of industries in the past few years. The relatively higher level of resistance wear and corrosion provided by these materials as compared to metals have increased their usage in medical devices and implants. Owing to their high transparency resistance, low weight, and high performance, the demand for sulfone polymers is also rising in the